The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has opined the drug major Lupin Limited to revise the proposed Phase III clinical ...
People living with severe mental illness face a substantially higher risk of dementia throughout adulthood, as well as a significantly elevated risk of stroke in early and middle ...
Shanghai: Swiss generic drugmaker Sandoz will pay up to USD 77 million upfront to Shanghai Henlius Biotech for rights to three biosimilar drugs to treat cholesterol, lupus and colorectal ...
India's pharmaceutical industry needs to move beyond its traditional strength in cost-effective generic medicines and focus on innovation, advanced manufacturing, quality and ...
Mumbai: CitiusTech, a digital and enterprise AI company serving healthcare and life sciences organizations, has elevated Dhaval Shah, Chief Business Officer for the MedTech (HMT) and Life ...
Biocon Limited's subsidiary in the United States has received supplemental U.S. Food and Drug Administration (FDA) approval for Yesintek 45 mg/0.5 ml single-dose prefilled ...
A new study published in The Journal of Asthma showed that the fixed-dose combination (FDC) of montelukast and acebrophylline showed a good safety profile and was linked to improvements in ...
Bengaluru: AstraZeneca is discontinuing a late-stage trial that tested experimental drug volrustomig plus chemotherapy in patients with metastatic non-small cell lung cancer, it said on ...
USA: A study published in Clinical Infectious Diseases found that extending the duration of antibiotic therapy after debridement, antibiotics, and implant retention (DAIR) for acute postoperative ...
How long do opioid-naive patients really need opioids for acute pain—and how much do they actually use? In the largest prospective cohort of its kind, researchers tracked real-world opioid ...
Researchers have found in a new study that topical finasteride 0.25% monotherapy was well tolerated and significantly improved hair density, hair thickness, and the terminal-to-vellus hair ...
Australia: Researchers have found in a target trial emulation study that preoperative use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) was associated with a significantly lower risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results